Ngā hua rapu - Peng‐Hui Wang

Whakamahine hua
  1. 1
    Lymphedema and sentinel lymph node mapping

    Lymphedema and sentinel lymph node mapping mā Peng-Hui Wang

    I whakaputaina 2025
    Whiwhi kuputuhi katoa
    Editorial
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Aberrant sialylation in ovarian cancers

    Aberrant sialylation in ovarian cancers mā Wen-Ling Lee, Peng‐Hui Wang

    I whakaputaina 2020
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Minimally invasive approach is preferred for clinical stage 1 endometrioid-type endometrial cancer

    Minimally invasive approach is preferred for clinical stage 1 endometrioid-type endometrial cancer mā Peng‐Hui Wang, Szu‐Ting Yang

    I whakaputaina 2024
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Current genetic test for ovarian cancer

    Current genetic test for ovarian cancer mā Szu‐Ting Yang, Peng-Hui Wang

    I whakaputaina 2025
    Whiwhi kuputuhi katoa
    Editorial
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Mesenchymal stem cell in wound healing and regeneration

    Mesenchymal stem cell in wound healing and regeneration mā Hsiao‐Wen Tsai, Peng‐Hui Wang, Kuan‐Hao Tsui

    I whakaputaina 2017
    Whiwhi kuputuhi katoa
    Carta
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    The selection of immune checkpoint inhibitors of programmed cell death (anti-PD-1) and its ligand (anti-PD-L1) makes matters more challenges for clinical practice

    The selection of immune checkpoint inhibitors of programmed cell death (anti-PD-1) and its ligand (anti-PD-L1) makes matters more challenges for clinical practice mā Peng‐Hui Wang, Szu‐Ting Yang, Chia‐Hao Liu

    I whakaputaina 2024
    Whiwhi kuputuhi katoa
    Editorial
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Antibody–drug conjugates (ADCs) may be a big breakthrough in gynecologic cancer treatment (II): Anti-HER2/neu

    Antibody–drug conjugates (ADCs) may be a big breakthrough in gynecologic cancer treatment (II): Anti-HER2/neu mā Peng‐Hui Wang, Wei‐Ting Chao, Na-Rong Lee

    I whakaputaina 2024
    Whiwhi kuputuhi katoa
    Editorial
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Minimally invasive surgery for endometrial cancer: The better choice?

    Minimally invasive surgery for endometrial cancer: The better choice? mā Yiu‐Tai Li, Szu‐Ting Yang, Peng‐Hui Wang

    I whakaputaina 2024
    Whiwhi kuputuhi katoa
    Editorial
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Antibody–drug conjugates (ADCs) may be a big breakthrough in gynecologic cancer treatment (I)

    Antibody–drug conjugates (ADCs) may be a big breakthrough in gynecologic cancer treatment (I) mā Peng‐Hui Wang, Chia‐Hao Liu, Szu‐Ting Yang

    I whakaputaina 2024
    Whiwhi kuputuhi katoa
    Editorial
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Primary cytoreductive surgery for advanced epithelial ovarian cancer patients is still popular in gynecologic oncologists in Korea and Taiwan, particularly apparent in Taiwan

    Primary cytoreductive surgery for advanced epithelial ovarian cancer patients is still popular in gynecologic oncologists in Korea and Taiwan, particularly apparent in Taiwan mā Peng-Hui Wang, Szu‐Ting Yang, Jae‐Weon Kim

    I whakaputaina 2025
    Whiwhi kuputuhi katoa
    Editorial
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Application of 2023 FIGO staging system for 2019 FIGO stage I endometrial cancer

    Application of 2023 FIGO staging system for 2019 FIGO stage I endometrial cancer mā Peng‐Hui Wang, Tricia Dewi Anggraeni, Tofan Widya Utami

    I whakaputaina 2025
    Whiwhi kuputuhi katoa
    Editorial
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Minimally invasive surgery for earl-stage cervical cancer

    Minimally invasive surgery for earl-stage cervical cancer mā Peng‐Hui Wang, Brahmana Askandar Tjokroprawiro, Szu‐Ting Yang

    I whakaputaina 2025
    Whiwhi kuputuhi katoa
    Editorial
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Is it enough to use cisplatin-paclitaxel-bevacizumab along in the management of stage IVB cervical cancer patients?

    Is it enough to use cisplatin-paclitaxel-bevacizumab along in the management of stage IVB cervical cancer patients? mā Peng-Hui Wang, Tofan Widya Utami, Tricia Dewi Anggraeni

    I whakaputaina 2025
    Whiwhi kuputuhi katoa
    Editorial
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    The new hope to manage women with mismatch repair proficient endometrial cancer

    The new hope to manage women with mismatch repair proficient endometrial cancer mā Peng‐Hui Wang, Jen‐Ruei Chen, Byoung‐Gie Kim

    I whakaputaina 2025
    Whiwhi kuputuhi katoa
    Editorial
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Internal iliac artery blockade

    Internal iliac artery blockade mā I-Gung Li, Chia‐Hao Liu, Peng‐Hui Wang

    I whakaputaina 2025
    Whiwhi kuputuhi katoa
    Editorial
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Uterine artery blockage

    Uterine artery blockage mā I-Gung Li, Hung‐Hsien Liu, Peng‐Hui Wang

    I whakaputaina 2025
    Whiwhi kuputuhi katoa
    Editorial
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    The frontiers in gynecologic cancer management: Exploring the new hope to manage women with endometrial cancer by immunochemotherapy

    The frontiers in gynecologic cancer management: Exploring the new hope to manage women with endometrial cancer by immunochemotherapy mā Peng‐Hui Wang, Szu‐Ting Yang, Byoung‐Gie Kim

    I whakaputaina 2025
    Whiwhi kuputuhi katoa
    Editorial
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Is the less the better for early-stage low-risk cervical cancer?

    Is the less the better for early-stage low-risk cervical cancer? mā Peng-Hui Wang, Wei‐Ting Chao, Jae‐Weon Kim

    I whakaputaina 2025
    Whiwhi kuputuhi katoa
    Editorial
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Is the far-advanced endometrial cancer curable?

    Is the far-advanced endometrial cancer curable? mā Peng-Hui Wang, Chia‐Hao Liu, Wen‐Shiung Liou

    I whakaputaina 2025
    Whiwhi kuputuhi katoa
    Editorial
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Cervical cancer in Taiwan

    Cervical cancer in Taiwan mā Szu‐Ting Yang, Peng‐Hui Wang, Chyong‐Huey Lai

    I whakaputaina 2025
    Whiwhi kuputuhi katoa
    Editorial
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: